Senseonics Holdings Inc (NASDAQ:SENS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Thursday.

According to Zacks, “Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. “

Senseonics Holdings (NASDAQ:SENS) opened at 2.86 on Thursday. Senseonics Holdings has a 1-year low of $2.17 and a 1-year high of $4.24. The stock’s 50 day moving average price is $2.70 and its 200 day moving average price is $3.49. The company’s market cap is $267.10 million.

TRADEMARK VIOLATION NOTICE: This article was first posted by Financial Market News and is the propert of of Financial Market News. If you are reading this article on another publication, it was illegally copied and republished in violation of U.S. & international copyright laws. The correct version of this article can be accessed at

About Senseonics Holdings

Senseonics Holdings, Inc, formerly ASN Technologies, Inc, is a medical technology company. The Company is focused on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed to be an implantable CGM system to continually measure glucose levels in people with diabetes for a period of approximately 90 days.

5 Day Chart for NASDAQ:SENS

Get a free copy of the Zacks research report on Senseonics Holdings (SENS)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with's FREE daily email newsletter.